feed,title,long_url,short_url
Investors,Myovant Sciences Stock Crashes On Poor Trial Data For Prostate Cancer Treatment,https://www.investors.com/news/technology/myov-stock-dives-poor-data-prostate-cancer-treatment/,https://j.mp/3nc35No
